Position in AMGN
as of Mar 31, 2026
· filed Jun 3, 2026
Position Value
$33,756,137
+$1,431,002 QoQ
Shares Held
95,939
-2.9% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026NewEdge Advisors, LLC holds $721,115,080 across 17 Drug Manufacturers - General names. AMGN ranks #6 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
888,033 | $217,070,786 | |
| 2 | LLY |
ELI LILLY & Co
|
184,095 | $169,325,058 | |
| 3 | ABBV |
AbbVie Inc.
|
632,140 | $137,484,128 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
392,435 | $54,693,665 | |
| 5 | MRK |
Merck & Co., Inc.
|
341,876 | $41,124,264 | |
| 6 | AMGN |
Amgen Inc
This page
|
95,939 | $33,756,137 | |
| 7 | PFE |
Pfizer Inc
|
712,319 | $20,001,917 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
226,056 | $13,710,296 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33,756,137 | 95,939 | Shares | Sole | 2026-06-03 | |
| 2025-12-31 | $32,325,135 | 98,760 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $25,050,329 | 88,768 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $22,175,975 | 79,424 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $23,610,505 | 75,784 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $18,009,963 | 69,099 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $21,044,501 | 65,313 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $19,937,122 | 63,809 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $14,291,913 | 50,267 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $14,534,065 | 50,462 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $11,686,222 | 43,482 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $10,471,129 | 47,163 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $10,461,731 | 43,275 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $11,905,996 | 45,332 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,112,722 | 31,556 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,487,107 | 26,663 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $6,782,083 | 28,046 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,397,021 | 28,435 | Shares | Sole | 2022-02-17 | |
| 2021-09-30 | $2,673,009 | 12,570 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $3,495,131 | 14,339 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $4,398,463 | 17,678 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $4,910,401 | 21,357 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $8,419,558 | 33,127 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $5,691,065 | 24,129 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $4,605,214 | 22,716 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||